Get started
ARES CAPITAL CORPARES CAPITAL CORPARES CAPITAL CORP

ARES CAPITAL CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

9A2 chart


Full chart

Key facts today

ADMA Biologics made a $30 million paydown on its $62.5 million senior secured term loan facility with Ares Capital Corporation, resulting in a 29% reduction of its total gross debt to $75 million.
Analyze the impactAnalyze the impact

9A2 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.42 B‬ CHF
Dividend yield (indicated)
8.98%
Price to earnings Ratio (TTM)
8.338
Basic EPS (TTM)
2.225 CHF
Net income (FY)
‪1.28 B‬ CHF
Revenue (FY)
‪2.06 B‬ CHF
Shares float
‪642.25 M‬
Beta (1Y)
0.32

Employees


Employees (FY)
‪2.8 K‬
Change (1Y)
+250 +9.80%
Revenue / Employee (1Y)
‪735.49 K‬ CHF
Net income / Employee (1Y)
‪457.65 K‬ CHF

About Ares Capital Corporation


Sector
Finance
Industry
Investment Managers
CEO
R. Kipp deVeer
Website
arescapitalcorp.com
Headquarters
New York
Founded
2004
FIGI
BBG00LVD7Z41
Ares Commercial Finance provides asset-based cash flow solutions to small and middle-market companies. ACF works with borrowers to deliver creative, flexible, and comprehensive financing solutions. Ares Commercial Finance has the ability to structure and agent deals to support the growth and changing capital needs of clients. Their asset-based lines of credit may be structured as working capital financing, bridge financing, turnaround financing, acquisition financing, debtor-in-possession financing, and special accommodation financing.

Financials


Performance
Revenue to profit conversion
Earnings
Next:—

9A2 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

9A2 highest yielding bonds


ARCC5292536
Ares Capital Corporation 3.2% 15-NOV-2031
Yield to maturity
6.04%
Maturity date
Nov 15, 2031
US4010LBF9
ARES CAP. 24/29
Yield to maturity
5.73%
Maturity date
Mar 1, 2029
ARCC5807413
Ares Capital Corporation 5.95% 15-JUL-2029
Yield to maturity
5.67%
Maturity date
Jul 15, 2029
ARCC5197287
Ares Capital Corporation 2.875% 15-JUN-2028
Yield to maturity
5.60%
Maturity date
Jun 15, 2028
US4010LBE2
ARES CAP. 23/27
Yield to maturity
5.38%
Maturity date
Jan 15, 2027
ARCC5335712
Ares Capital Corporation 2.875% 15-JUN-2027
Yield to maturity
5.22%
Maturity date
Jun 15, 2027
ARCC5107541
Ares Capital Corporation 2.15% 15-JUL-2026
Yield to maturity
5.21%
Maturity date
Jul 15, 2026
ARCC5013168
Ares Capital Corporation 3.875% 15-JAN-2026
Yield to maturity
5.08%
Maturity date
Jan 15, 2026
ARCC4934572
Ares Capital Corporation 3.25% 15-JUL-2025
Yield to maturity
4.91%
Maturity date
Jul 15, 2025

Explore more bonds 

Frequently Asked Questions


The current price of 9A2 is 18.898 CHF — it has decreased by −3.27% in the past 24 hours. Watch ARES CAPITAL CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ARES CAPITAL CORP stocks are traded under the ticker 9A2.
9A2 stock has fallen by −3.27% compared to the previous week, the month change is a 0.57% rise, over the last year ARES CAPITAL CORP has showed a 8.29% increase.
We've gathered analysts' opinions on ARES CAPITAL CORP future price: according to them, 9A2 price has a max estimate of 22.85 CHF and a min estimate of 19.34 CHF. Watch 9A2 chart and read a more detailed ARES CAPITAL CORP stock forecast: see what analysts think of ARES CAPITAL CORP and suggest that you do with its stocks.
9A2 reached its all-time high on Nov 19, 2021 with the price of 19.585 CHF, and its all-time low was 16.515 CHF and was reached on Jul 17, 2023. View more price dynamics on 9A2 chart.
See other stocks reaching their highest and lowest prices.
9A2 stock is 3.38% volatile and has beta coefficient of 0.32. Track ARES CAPITAL CORP stock price on the chart and check out the list of the most volatile stocks — is ARES CAPITAL CORP there?
Today ARES CAPITAL CORP has the market capitalization of ‪12.42 B‬, it has decreased by −2.78% over the last week.
Yes, you can track ARES CAPITAL CORP financials in yearly and quarterly reports right on TradingView.
ARES CAPITAL CORP is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
9A2 earnings for the last quarter are 0.49 CHF per share, whereas the estimation was 0.50 CHF resulting in a −2.42% surprise. The estimated earnings for the next quarter are 0.52 CHF per share. See more details about ARES CAPITAL CORP earnings.
ARES CAPITAL CORP revenue for the last quarter amounts to ‪656.76 M‬ CHF, despite the estimated figure of ‪652.90 M‬ CHF. In the next quarter, revenue is expected to reach ‪706.10 M‬ CHF.
9A2 net income for the last quarter is ‪333.89 M‬ CHF, while the quarter before that showed ‪289.49 M‬ CHF of net income which accounts for 15.34% change. Track more ARES CAPITAL CORP financial stats to get the full picture.
Yes, 9A2 dividends are paid quarterly. The last dividend per share was 0.43 CHF. As of today, Dividend Yield (TTM)% is 8.98%. Tracking ARES CAPITAL CORP dividends might help you take more informed decisions.
ARES CAPITAL CORP dividend yield was 9.59% in 2023, and payout ratio reached 71.74%. The year before the numbers were 10.12% and 157.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 21, 2024, the company has ‪2.80 K‬ employees. See our rating of the largest employees — is ARES CAPITAL CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARES CAPITAL CORP EBITDA is ‪1.99 B‬ CHF, and current EBITDA margin is 86.84%. See more stats in ARES CAPITAL CORP financial statements.
Like other stocks, 9A2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARES CAPITAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARES CAPITAL CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARES CAPITAL CORP stock shows the neutral signal. See more of ARES CAPITAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.